Naturalistic Monitoring & Treatment of Chronic Insomnia

Status Completed

Clinical Trial Summary

90 individuals with chronic insomniacs and 30 healthy normal sleepers will have their sleep monitored by the SleepScore Max for 10 weeks. Individuals with chronic insomnia will be randomized into one of three groups (30 subjects in each): a test intervention group, a passive control group, and an active control group. The purpose of the study is to examine if the SleepScore max provides a accurate measurement of sleep relative to a validated, wrist-worn sleep monitor and if a integrated coaching feature within the SleepScore Max facilitates improvement in sleep relative to other gold standard treatment methods.

Clinical Trial Description

90 chronic insomniacs, carefully screened using the criteria of Chronic Insomnia Disorder according to the International Classification of Sleep Disorders 3 (ICSD-3), will be studied. Additionally, 30 healthy normal sleepers will be included as controls. The duration of study participation will be 10 weeks. All subjects will wear an actigraph during week 1 to record baseline sleep patterns, followed by 8 weeks of recording with the SleepScore Max. During week 10, the subjects will wear the actigraph again to measure post intervention sleep. The healthy subjects will be used as a control to test if the SleepScore Max can track sleep well as compared to actigraphy. The subjects with chronic insomnia will be randomized into one of three groups (30 subjects in each). One of these groups is the test intervention group, in which subjects will track their sleep with the SleepScore Max device and will receive feedback and coaching from the Smartphone app associated with the device. The other two groups will serve as passive and active controls. The passive control group will track their sleep using the SleepScore Max device, but without any feedback or coaching. The active control group will also be tracking their sleep with the device, without feedback or coaching, but they will also undergo online CBTi which is a user guided program to track sleep, receive sleep coaching, and initiate behavioral techniques such as tailored sleep scheduling and sleep hygiene to help improve sleep. ;

Study Design

Related Conditions & MeSH terms

Chronic Insomnia
Sleep Initiation and Maintenance Disorders

Clinical Trial Details

NCT number	NCT04013321
Study type	Interventional
Source	Washington State University
Contact
Status	Completed
Phase	N/A
Start date	January 23, 2020
Completion date	October 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03171519` - Effects of Exercise and Acupuncture on Chronic Insomnia	N/A
Completed	`NCT02515006` - Impact of Homeopathy for Persistent Insomnia in Patients With Cancer	N/A
Recruiting	`NCT05247697` - Mirtazapine for Chronic Insomnia in Older Adults	Phase 1
Active, not recruiting	`NCT04350866` - Enhancing Access to Insomnia Care in VA PCMHI Clinics
Active, not recruiting	`NCT04366284` - Optimizing the Scalability of Evidence-Based Behavioral Sleep Medicine Practices With a Digital Health Platform	N/A
Recruiting	`NCT04761796` - Sleep Time and Insomnia Factors Among Professional Flight Members
Completed	`NCT02688569` - Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study	N/A
Completed	`NCT02236845` - Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients	N/A
Completed	`NCT01949389` - Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders	N/A
Completed	`NCT00414102` - Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.	Phase 4
Completed	`NCT00671294` - Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.	Phase 3
Completed	`NCT02392000` - Mobile Sleep Intervention for OEF, OIF and OND Veterans	N/A
Recruiting	`NCT04471168` - Interest of Auriculotherapy in the Management of Chronic Insomnia	N/A
Completed	`NCT02774642` - Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)	N/A
Completed	`NCT02290405` - Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
Recruiting	`NCT05618002` - Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
Completed	`NCT01995838` - A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia	Phase 2
Recruiting	`NCT05457790` - Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)	N/A
Active, not recruiting	`NCT02272712` - The Effectiveness of Online Treatment for Insomnia in Cancer Survivors	N/A
Completed	`NCT00915135` - Efficacy and Safety of Ramelteon on Chronic Insomnia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Naturalistic Monitoring and Treatment of Chronic Insomnia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms